These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4235081)

  • 21. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 22. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
    Ason EK; Hetzel BS; Good BF; Stenhouse NS
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thyroid acropachy with an abnormally high concentration of long acting thyroid stimulator].
    Momotani N; Suzuki T; Harada S; Nishikawa Y; Ito K
    Horumon To Rinsho; 1972 Aug; 20(8):649-53. PubMed ID: 4678862
    [No Abstract]   [Full Text] [Related]  

  • 24. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
    Winand R
    Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Depisch D; Höfer R; Schatz H
    Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 28. The long-acting thyroid stimulator of Graves' disease.
    Burke G
    Am J Med; 1968 Sep; 45(3):435-50. PubMed ID: 4876801
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: hyperthyroidism and Grave's disease.
    Br Med J; 1975 May; 2(5969):457-8. PubMed ID: 1173788
    [No Abstract]   [Full Text] [Related]  

  • 31. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1968 Mar; 28(3):325-31. PubMed ID: 5642686
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 34. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 36. [Graves-Basedow disease, Hashimoto's disease, and myxedema from spontaneous atrophy of the thyroid. Characteristics relative to these clinical entities].
    Hennen G; Betz EH
    Acta Clin Belg; 1968; 23(1):7-22. PubMed ID: 4174753
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current physiopathology of Basedow's disease].
    Saltiel H; Schaison G; Valcke JC
    Presse Med (1893); 1969 Oct; 77(45):1605-8. PubMed ID: 4189478
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunoassay of thyroid-stimulating hormone and its clinical applications.
    Hall R
    Clin Endocrinol (Oxf); 1972 Jan; 1(1):115-25. PubMed ID: 4200175
    [No Abstract]   [Full Text] [Related]  

  • 39. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 40. L.A.T.S. and Graves' disease.
    Hedley AJ; Ross IP; Crooks J
    Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.